Paul Liknaitzky Lab

Welcome to
The Clinical Psychedelic Research Lab

Australia's first psychedelic lab, establishing a rigorous program of research in psychedelic medicine at Monash University that seeks to evaluate therapeutic effects, innovate on treatment design, mitigate known risks, explore potential drawbacks, and understand therapeutic mechanisms.

The Lab is led by Dr Paul Liknaitzky.

The Lab is part of the School of Psychological Sciences within the Turner Institute for Brain and Mental Health, and the Department of Psychiatry within the School of Clinical Sciences.

Latest announcement - Participants wanted for The Monash Psychedelic Experience and Effects Survey

December 2021: If you have had a psychedelic experience within the past two years, we’d love to ask you about your experiences! Participants will complete a 50-minute online survey and have a chance to win one of several $100 gift vouchers. Results from this survey will inform clinical psychedelic trials currently in development. Identifying information will not be collected. You may also be eligible to participate in a follow-up survey about your experiences.

To participate or for more information, please visit MonashPsychedelic.org